XML 105 R87.htm IDEA: XBRL DOCUMENT
v3.20.2

Revenue from Contracts with Customers - Schedule of Disaggregation of Revenue (Details) - USD ($) $ in Thousands | 12 Months Ended
--- | ---
Oct. 03, 2020 | Sep. 28, 2019
Disaggregation of Revenue [Line Items] |  |
Revenue from Contract with Customer | $ 3,501,782 | $ 3,296,446
Operating Segments |  |
Disaggregation of Revenue [Line Items] |  |
Revenue from Contract with Customer | 3,390,394 | 3,164,434
Elimination of inter-segment sales |  |
Disaggregation of Revenue [Line Items] |  |
Revenue from Contract with Customer | 111,388 | 132,012
Healthcare/Life Sciences | Operating Segments |  |
Disaggregation of Revenue [Line Items] |  |
Revenue from Contract with Customer | 1,258,385 | 1,219,998
Industrial/Commercial | Operating Segments |  |
Disaggregation of Revenue [Line Items] |  |
Revenue from Contract with Customer | 1,254,564 | 981,220
Aerospace/Defense | Operating Segments |  |
Disaggregation of Revenue [Line Items] |  |
Revenue from Contract with Customer | 611,568 | 588,600
Communications | Operating Segments |  |
Disaggregation of Revenue [Line Items] |  |
Revenue from Contract with Customer | 265,877 | 374,616
AMER |  |
Disaggregation of Revenue [Line Items] |  |
Revenue from Contract with Customer | 1,327,849 | 1,429,308
AMER | Operating Segments |  |
Disaggregation of Revenue [Line Items] |  |
Revenue from Contract with Customer | 1,317,120 | 1,422,313
AMER | Elimination of inter-segment sales |  |
Disaggregation of Revenue [Line Items] |  |
Revenue from Contract with Customer | 10,729 | 6,995
AMER | Healthcare/Life Sciences | Operating Segments |  |
Disaggregation of Revenue [Line Items] |  |
Revenue from Contract with Customer | 464,134 | 488,851
AMER | Industrial/Commercial | Operating Segments |  |
Disaggregation of Revenue [Line Items] |  |
Revenue from Contract with Customer | 324,120 | 359,381
AMER | Aerospace/Defense | Operating Segments |  |
Disaggregation of Revenue [Line Items] |  |
Revenue from Contract with Customer | 371,685 | 317,558
AMER | Communications | Operating Segments |  |
Disaggregation of Revenue [Line Items] |  |
Revenue from Contract with Customer | 157,181 | 256,523
APAC |  |
Disaggregation of Revenue [Line Items] |  |
Revenue from Contract with Customer | 1,824,831 | 1,557,205
APAC | Operating Segments |  |
Disaggregation of Revenue [Line Items] |  |
Revenue from Contract with Customer | 1,730,476 | 1,437,708
APAC | Elimination of inter-segment sales |  |
Disaggregation of Revenue [Line Items] |  |
Revenue from Contract with Customer | 94,355 | 119,497
APAC | Healthcare/Life Sciences | Operating Segments |  |
Disaggregation of Revenue [Line Items] |  |
Revenue from Contract with Customer | 618,250 | 602,922
APAC | Industrial/Commercial | Operating Segments |  |
Disaggregation of Revenue [Line Items] |  |
Revenue from Contract with Customer | 850,662 | 534,971
APAC | Aerospace/Defense | Operating Segments |  |
Disaggregation of Revenue [Line Items] |  |
Revenue from Contract with Customer | 157,301 | 186,486
APAC | Communications | Operating Segments |  |
Disaggregation of Revenue [Line Items] |  |
Revenue from Contract with Customer | 104,263 | 113,329
EMEA |  |
Disaggregation of Revenue [Line Items] |  |
Revenue from Contract with Customer | 349,102 | 309,933
EMEA | Operating Segments |  |
Disaggregation of Revenue [Line Items] |  |
Revenue from Contract with Customer | 342,798 | 304,413
EMEA | Elimination of inter-segment sales |  |
Disaggregation of Revenue [Line Items] |  |
Revenue from Contract with Customer | 6,304 | 5,520
EMEA | Healthcare/Life Sciences | Operating Segments |  |
Disaggregation of Revenue [Line Items] |  |
Revenue from Contract with Customer | 176,001 | 128,225
EMEA | Industrial/Commercial | Operating Segments |  |
Disaggregation of Revenue [Line Items] |  |
Revenue from Contract with Customer | 79,782 | 86,868
EMEA | Aerospace/Defense | Operating Segments |  |
Disaggregation of Revenue [Line Items] |  |
Revenue from Contract with Customer | 82,582 | 84,556
EMEA | Communications | Operating Segments |  |
Disaggregation of Revenue [Line Items] |  |
Revenue from Contract with Customer | $ 4,433 | $ 4,764

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_DisaggregationOfRevenueLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 4 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 924 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 11.L) -URI http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856 + Details
Name: | us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=plxs_HealthcareLifeSciencesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=us-gaap_CommercialAndIndustrialSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=plxs_AerospaceDefenseMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=plxs_CommunicationsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=srt_AmericasMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=srt_AsiaPacificMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=us-gaap_EMEAMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |